Stay updated on Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Removed related topic links 'Lung Cancer' and 'MedlinePlus Genetics' from the Study Details page. This reduces navigational context but does not affect the core study information.
    Difference
    0.1%
    Check dated 2026-01-10T01:35:11.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Lung cancer is added as a related topic and MedlinePlus Genetics is linked under related topics; no core study data, eligibility criteria, or outcomes were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-26T16:20:44.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Minor UI label updates (Locations, Massachusetts) and revision tags, with removal of some footer/related-topic labels; no core study content changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-12-19T10:47:36.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The page now displays related topics 'Lung cancer' and 'MedlinePlus Genetics' to guide readers to related resources.
    Difference
    0.1%
    Check dated 2025-12-12T05:43:07.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Lung cancer and the MedlinePlus Genetics related topic were removed from the page's topics/related topics. This reduces disease-specific tagging and cross-links on the page.
    Difference
    0.1%
    Check dated 2025-12-05T02:25:09.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The page now includes Lung cancer and MedlinePlus Genetics related topics. The revision label was updated from v3.3.1 to v3.3.2.
    Difference
    0.2%
    Check dated 2025-11-27T23:24:05.000Z thumbnail image

Stay in the know with updates to Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial page.